Factors Affecting Physician's Behavior to Prescribe General Medicines in Pharmaceutical sector in egypt
Mohamed Helal Al-Siufy
Dr . Ramy William
This kind of paper was submitted in partial happiness of the requirements for the level of
MASTER OF BUSINESS OPERATIONS
Victoria Institution of Supervision
1 . 1 OVERVIEW
Experts argue that generics became generally prescribed by physicians especially since nineties when value & monetary factors started to be the main focus of both governments and individuals as well. Generic drugs product sales reported Bn 13. your five LE adding 45% of total pharmaceutical drug market in Egypt (IMS Sales YTD 12/2014) while 5 away of top 10 companies in Egypt are local corporations (generic-producing firms) reported Bn 4. almost eight LE (IMS Sales YTD 12/2014). Authorities & insurance companies exerts pressure on physicians to switch coming from brand-name to generic drugs especially for common, well-established drugs used in the treating common, secret diseases (eg: common frosty, dyslipidemia…etc) due to economic element in order to spend less to enable them to pay for new high-tech drugs treating difficult, life-threatening diseases (eg: cancer, AIDS….. etc). ALL OF US Food & Drug Supervision (FDA) put into action strict rules for permit of generic drugs. One of these guideline is the fact generics must be at least 90% bioequivalent (identical) to brand-name medicines with regards to efficacy & protection (Epilepsia, 49(Suppl. 9): 56–62, 2008). Use of generics rather than brand-name medicines in certain diseases (eg: epilepsy) still debatable as per (Frederick Andermann ainsi que al. 2007). Another study indicated that patient's frame of mind towards generics is bettering by time (Mohamed A. A. Hassali 2009). Many factors will be contributed in selecting generics over brand-name drugs including price, quality of generics and marketing efforts simply by pharmaceutical companies as per (Eric Campbell 2013). Researcher claim that other factors instead of price impacting physician's prescription behavior of generics which includes Ego of physician & patient's attitude towards generic drugs. Additionally, there are moderating variables that influence physician's behavior including disease type & medicine type. The researcher claims that pharmaceutical industry in Egypt is lacking in such info, hence the outcomes of this kind of research could possibly be beneficial in such sector.
1 . 2 INTRODUCTION
As previously mentioned, general drugs are commonly used because the last two decades mainly as a result of economic factors. Governments need physicians to change from name brand drugs to generic medications especially for prevalent diseases to save money to be utilized in money new medications for severe, life-threatening conditions (eg: cancer, AIDS….. etc). Insurance companies while exerts pressure for moving over to general drugs as well in order to account the very expensive medications (eg: biogenetics, hormones…etc). Patients also pressurize physicians to prescribe less expensive drugs in order to save money financed on other life requirements such as education, nutrition…etc. The main reason for switching to generics seems to be price however there might be another elements affecting prescription behavior of physicians which can be quality of generics chosen, type of diseases, type of medications, marketing work of medicine makers or perhaps ego of physicians who have might reject generics especially in their non-public clinics & hospitals. FOOD AND DRUG ADMINISTRATION & well being authorities put into action rigorous circumstances for permit of generics. One of these variables is generics should be bioequivalent (identical) to get minimum 90% of brand-name drugs.
1 . 3 ISSUE DEFINITION
Deficiency of local data on elements affecting physicians to recommend generics over brand-name medicines. The Leading understanding of number of generic above brand-name medicines is due to cost factor only. Market share of local generic companies keeps growing sharply, so researcher thinks the selection of generics influenced by...
References: 1- IMS Product sales YTD 12/2014
2- Joshua Campbell. 1/4 of Paperwork Often Recommend Brand-Name Drugs Over Generics: Study. January. 7, 2013, JAMA Interior Medicine, on-line
3- Market Feedback. Interview with Doctor A. Okasha (Professor of Psychiatry, former head of world psychiatry society)
4- Are Brand-Name and Generic Drugs Truly the Same? The Prescriber Perspective. Laurie Scudder, DNP, NP, September 18, 2012. www.medscape.com
5- Mohamed A. A. Hassali. Customers' views on generic medicines: a review of the books. International Record of Drug-store Practice 2009; 17: 79–88
6- Frederick Andermann. Required Generic Transitioning of Antiepileptic Drugs: Excessive Switchback Prices to Top quality Compounds Compared with Other Medicine Classes. Epilepsia, 48(3): 464–469, 2007
7- Frederick Andermann. Compulsory Generic Switching of Antiepileptic Drugs: High Switchback Rates to Branded Substances Compared with Additional Drug Classes. Epilepsia, 48(3): 464–469, 2007
8- Harold Helderman. Common Substitution pertaining to Immunosuppressive Drugs. Dialysis & Transplantation January 2011
9- Barry At the. Gidal and yTorbjo¨rn Tomson. Debate: Replacement of generic drugs in epilepsy: Perhaps there is cause for matter? Epilepsia, 49(Suppl. 9): 56–62, 2008